MustGrow Biologics Corp. (TSXV:MGRO)
0.6300
+0.0300 (5.00%)
Dec 1, 2025, 9:30 AM EST
MustGrow Biologics Revenue
MustGrow Biologics had revenue of 789.18K CAD in the quarter ending September 30, 2025, with 182.68% growth. This brings the company's revenue in the last twelve months to 7.54M, up 51.04% year-over-year. In the year 2024, MustGrow Biologics had annual revenue of 398.02K, down -91.55%.
Revenue (ttm)
7.54M
Revenue Growth
+51.04%
P/S Ratio
4.68
Revenue / Employee
n/a
Employees
n/a
Market Cap
35.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 398.02K | -4.31M | -91.55% |
| Dec 31, 2023 | 4.71M | 4.71M | 72,630.36% |
| Dec 31, 2022 | 6.48K | -6.39K | -49.65% |
| Dec 31, 2021 | 12.87K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nutrien | 35.76B |
| Barrick Mining | 20.34B |
| Teck Resources | 10.48B |
| Kinross Gold | 8.98B |
| First Quantum Minerals | 6.99B |
| Lundin Mining | 5.25B |
| Pan American Silver | 4.53B |
| Wheaton Precious Metals | 2.55B |
MustGrow Biologics News
- 3 months ago - MustGrow Biologics Corp. GAAP EPS of -$0.02 beats by $0.02, revenue of $2.8M misses by $2.4M - Seeking Alpha
- 6 months ago - MustGrow Biologics GAAP EPS of -C$0.03 - Seeking Alpha
- 7 months ago - MustGrow Biologics accelerates regenerative agriculture with NexusBioAg acquisition - BNN Bloomberg
- 1 year ago - MustGrow Biologics proposes ~$2M private placement - Seeking Alpha